‘Shredding’ cancer cells: Study of CRISPR-Cas3 brings us a step closer
https://as.cornell.edu/news/shredding-cancer-cells-study-crispr-cas3-brings-us-step-closer
By Kate Blackwood, A&S Communications
Dive into the revolutionary world of CRISPR-Cas3, a cutting-edge enzyme that holds the potential to transform biology as we know it. As a standout component of the CRISPR systems naturally present in immune systems, CRISPR-Cas3 offers unparalleled promise in genetic editing and disease treatment. Discover how this groundbreaking technology is reshaping the scientific landscape, fueling excitement and anticipation for its far-reaching applications. Prepare to be captivated by the limitless possibilities that CRISPR-Cas3 presents, and join the forefront of pioneering research and innovation.